Harmony Biosciences Holdings (HRMY) — Cash Flow Reinvestment Rate
Harmony Biosciences Holdings (HRMY) has a Cash Flow Reinvestment Rate of 5.46x as of March 2026, reinvesting $151.65 Million (capex $0.00 plus investments $-151.65 Million) from operating cash flow of $27.76 Million. Check Harmony Biosciences Holdings (HRMY) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Harmony Biosciences Holdings Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Harmony Biosciences Holdings across 5 annual periods. Explore Harmony Biosciences Holdings (HRMY) long-term investment share to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Harmony Biosciences Holdings (2021–2025)
Year-by-year capital reinvestment analysis for Harmony Biosciences Holdings. For live market cap and broader valuation context, see how much is Harmony Biosciences Holdings worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.02x | $5.40 Million | $348.20 Million | $310.00K | ▼ -95.0% |
| 2024 | 0.31x | $68.64 Million | $219.82 Million | $1.15 Million | ▲ +19.0% |
| 2023 | 0.26x | $57.58 Million | $219.39 Million | $312.00K | ▼ -73.3% |
| 2022 | 0.98x | $142.00 Million | $144.47 Million | $172.00K | ▼ -3.7% |
| 2021 | 1.02x | $100.60 Million | $98.56 Million | $298.00K | — |